A novel glaucoma treatment drug research through caspase siRNA.
| Project/Area Number |
21592260
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Ophthalmology
|
|---|
| Research Institution | Saga University |
|---|
Principal Investigator |
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
HIRATA Akira 佐賀大学, 医学部, 准教授 (60295144)
ISHIKAWA Shinichiro 佐賀大学, 医学部, 助教 (00404129)
|
|---|
| Project Period (FY) |
2009 – 2011
|
| Project Status |
Completed (Fiscal Year 2011)
|
| Budget Amount *help |
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2011: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2010: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2009: ¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
|
|---|
| Keywords | 遺伝子 / 細胞・組織 / 蛋白質 / 神経保護 / アポトーシス / 網膜視神経節細胞 / 緑内障 / 組織・細胞 |
|---|
| Research Abstract |
Intra-vitreous injection of atelocollagen and caspase-3 siRNA complex may protect the retinal ganglion cell damage induced by transient ischemic injury(a glaucoma animal model).
|
Report
(4 results)
Research Products
(8 results)
